Research for new drugs for elimination of onchocerciasis in Africa
Onchocerciasis is a parasitic, vector borne disease caused by the filarial nematode Onchocerca volvulus. More than 99% of the population at risk of infection live in Africa. Onchocerciasis control was initiated in West Africa in 1974 with vector control, later complemented by ivermectin mass drug ad...
Main Author: | Annette C. Kuesel |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2016-12-01
|
Series: | International Journal for Parasitology: Drugs and Drug Resistance |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S221132071630015X |
Similar Items
-
Elimination of onchocerciasis in Africa by 2025: the need for a broad perspective
by: Ed Cupp, et al.
Published: (2019-07-01) -
Reaching the last mile: main challenges relating to and recommendations to accelerate onchocerciasis elimination in Africa
by: Gebremedhin Gebrezgabiher, et al.
Published: (2019-07-01) -
Elimination of onchocerciasis in Ecuador: findings of post-treatment surveillance
by: Ángel Guevara, et al.
Published: (2018-04-01) -
Elimination of onchocerciasis in Africa by 2025: an ambitious target requires ambitious interventions
by: Robert Colebunders, et al.
Published: (2019-10-01) -
Onchocerciasis Elimination: Progress and Challenges
by: Lakwo T, et al.
Published: (2020-10-01)